Conjugation of hydrophobic drugs to motile pRNA 4WJ nanoparticles for spontaneous tumor targeting and undetectable toxicity

Key Points

• Tumor targeting is enhanced with motile pRNA nanoparticles, enabling effective delivery of hydrophobic drugs.
• Key evidence highlights that the conjugation method maintains low toxicity levels while treating tumors.
• Assessment using motile pRNA nanoparticles demonstrates spontaneous targeting in tumor environments.
• These findings may enable safer drug delivery systems, although further testing in clinical settings is needed.